Earlier quoted context omitted.
Why are you continuing to misrepresent the EUA documents? They don’t support your assertion. (If you point to where in the authorization docs they specify the goal is to prevent SARS-CoV-2 infection, I’ll change my mind. I linked the moderna application in another sub thread, and the pfizer one is easy to find) Also VAERS is not the only data source we have for vaccine safety, it’s our hypothesis generation system. W…
They clearly do, it is like the very first sentence: https://labeling.pfizer.com/ShowLabeling.aspx?id=14471&forma... > The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Pfizer-BioNTech COVID-19 Vaccine, for active immunization to prevent COVID-19 in individuals 5 years of age and older. https://www.modernatx.com/covid19va…
> Note: Confirmed cases were determined by Reverse Transcription-Polymerase Chain Reaction (RT-PCR) and at least 1 symptom consistent with COVID-19 (symptoms included: fever; new or increased cough; new or increased shortness of breath; chills; new or increased muscle pain; new loss of taste or smell; sore throat; diarrhea; vomiting)
That’s kind of squishy, but I think it’s a clear distinction.
I agree that the effectiveness against symptomatic Covid is lower with omicron, but omicron also evades immunity from prior infection as well.